Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000913531 | SCV001058680 | likely benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004029367 | SCV003541132 | uncertain significance | not specified | 2025-01-09 | criteria provided, single submitter | clinical testing | The c.109C>G (p.L37V) alteration is located in exon 5 (coding exon 1) of the EDC3 gene. This alteration results from a C to G substitution at nucleotide position 109, causing the leucine (L) at amino acid position 37 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |